Stocks to buy

Gene editing is revolutionizing how the world approaches medicine. In fact, by “simply” removing cells from the body, editing them, and reintroducing them, we could help treat sickle-cell anemia, cancers, blood disorders, blindness, cystic fibrosis, and even muscular dystrophy if all goes according to plan. But that’s just the start. As things progress, it may
0 Comments
A double-edged sword if there ever was one, the September jobs report effectively put the Federal Reserve in a bind, catalyzing the case for stocks for rising interest rates. Sure, on the one hand, most governments aim for a robust labor market. Happy, employed workers obviously tend to be satisfied, thus reducing pressure on policymakers.
0 Comments
In the last few years, short-squeeze stocks investing gained prominence in the euphoria of 2021. Retail investors targeted stocks that have a high short interest. When the stock started trending higher, shorts were covered, resulting in a massive rally in quick time. There were multibagger stories in a matter of weeks. Of course, GameStop (NYSE:GME)
0 Comments
Of the 500 stocks listed in the benchmark S&P 500 index, only 51 (10%) are considered dividend kings and have increased their dividend payout to stockholders for 50 consecutive years or longer. Dividend kings are often stocks of long-established blue-chip companies that have prioritized returning capital to their shareholders through consistent dividend payments. These companies
0 Comments
During the pandemic era, several healthcare stocks skyrocketed. The focus was, however, on biopharma companies with an early-mover advantage related to the vaccine against Covid-19. Sentiments have changed drastically in a post-pandemic era with 2023 being a subdued year for healthcare stocks. However, there is no doubt about the point that global healthcare spending will
0 Comments
When you’re looking for good investment options in the fourth quarter, top tech stocks should be at the top of your list. And the best way to evaluate tech stocks is by using the Portfolio Grader. Tech companies, by nature, are innovative and, therefore, are in the best position to capitalize on emerging trends and
0 Comments
In 2023, a year when the market has heavily favored technology stocks, drugmakers like Pfizer (NYSE:PFE) seem to have been left behind. However, if PFE stock is trading at a low price and Pfizer rewards its loyal shareholders with substantial dividend distributions, then value-focused investors should be buyers, not sellers. Not only that, but I
0 Comments
Airline stocks are always exciting for investors to consider. On one hand, airliners are highly cyclical businesses, creating risk for investors to monitor. On the other hand, many of these airlines demonstrate great potential. This is especially true as they navigate their post-pandemic recoveries and continue to return to growth. Although investors need to be
0 Comments
Due to the rapid commercialization of spacecraft among government, industrial, and commercial use, space stock mania is emerging. Soon these companies will boost to new heights, thereby leading us into new realms of travel. One of the shiniest benefits of these space stocks is their attractive valuations, making them a catch as aggressive growth stocks
0 Comments